Antitumor Effect of Mesenchymal Stem Cells from Murine in Breast Cancer in Female Rats | ||||
| Benha Veterinary Medical Journal | ||||
| Article 37, Volume 35, Issue 1, September 2018, Page 369-374 PDF (693.36 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/bvmj.2018.39664 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Omayma A.R. AbouZaid1; Laila A Rashed2; S. M. El-Sonbaty3; Aboel-Ftouh A. I4 | ||||
| 1of Clinical Biochemistry, Faculty of Veterinary Medicine, Benha University | ||||
| 2Department of Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo, Egypt | ||||
| 3Assistant Professor Microbiology department, National center for Radiation Research and Technology ,Atomic Energy Authority, Cairo, Egypt, | ||||
| 4Biochemistry department, Faculty of Veterinary Medicine, Benha University | ||||
| Abstract | ||||
| The aim of this study was to evaluate the effect of mesenchymal stem cells as a treatment against breast cancer via modulation TGF-β. Mesenchymal stem cells (MSCs) are recruited to the stroma of cancers. They interact with cancer cells to promote invasion and metastasis or to suppress tumor growth. The unique tumor-homing capacity of MSCs makes them a promising vehicle to deliver various anticancer agents. | ||||
|
Statistics Article View: 82 PDF Download: 213 |
||||
